CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice

The main challenge of adoptive therapy with Chimeric Antigen Receptor modified T cells (CAR T) is the application to the field of solid tumors, where the identification of a proper antigen has emerged as one of the major drawbacks to CAR T cell treatment success. CD44 is a glycoprotein involved in c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Porcellini, Simona, Asperti, Claudia, Corna, Stefano, Cicoria, Eleonora, Valtolina, Veronica, Stornaiuolo, Anna, Valentinis, Barbara, Bordignon, Claudio, Traversari, Catia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7010926/
https://ncbi.nlm.nih.gov/pubmed/32117253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00099
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller